Prescient Investment Analysis
Value, growth at reasonable price, long/short equity, bankruptcy situations

Qualifying Speculation In Omeros Corporation

"My Fall was stopped by a terrible Squash, that sounded louder to mine Ears than the Cataract of Niagara; after which I was quite in the dark for another Minute and then my Box began to rise so high that I could see Light from the tops of my Windows." - Jonathan Swift, Gulliver's Travels

Introduction

Omeros Corporation is a small-cap biopharmaceutical firm that is competing with big drug companies. It is not a new situation, and the latter parties have been shown to select experimental drugs with higher success rates. However, over the past year and a half, multiple things have consistently improved at Omeros. It now has two products that have advanced to Phase II, from preclinical...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
FREESA PRO MEMBERS
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details